SERUM-LIPIDS AND BREAST-CANCER RISK - A COHORT STUDY OF 5,207 DANISH WOMEN

被引:79
作者
HOYER, AP
ENGHOLM, G
机构
关键词
BREAST CANCER RISK; COHORT STUDY; DENMARK; HDL-CHOLESTEROL; SERUM LIPIDS;
D O I
10.1007/BF00051352
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The association between serum lipids and breast cancer risk was investigated in a cohort of 5,207 Danish women, who participated in The Glostrup Population Studies between 1964 and 1986. During four to 26 years of follow-up, 51 incident cases of breast cancer were identified by linkage to the Danish Cancer Registry. At the time of lipid measurement, the women were between 30 and 80 years of age. An inverse association was found between serum high-density lipoprotein (HDL) cholesterol and risk of breast cancer, which was not changed by adjustment for potential confounders such as social class, age at menarche and menopause, number of full-term pregnancies, body mass index, or alcohol and coffee consumption. The relative risk was 0.3 (95 percent confidence interval = 0.1-0.8) for women in the highest quartile of serum HDL-cholesterol compared with women in the lowest quartile and the relation displayed a significant negative trend (P = 0.01). For serum triglycerides there was a suggestion of a positive association with breast cancer incidence, but the trend was not significant (P = 0.06). No relationship between total serum cholesterol or low-density lipoprotein cholesterol and risk of breast cancer was observed. Risk estimates for well known breast cancer risk factors such as social class, age at menopause, number of full-term pregnancies, and obesity were in the directions expected.
引用
收藏
页码:403 / 408
页数:6
相关论文
共 36 条
[1]  
Kelsey J.L., Gammon M.D., Epidemiology of breast cancer, Epidemiol Reviews, 12, pp. 228-40, (1990)
[2]  
Metabolic epidemiology of plasma cholesterol. Mechanisms of variation of plasma cholesterol within populations and between populations, Lancet, 2, pp. 991-7, (1986)
[3]  
Shekelle R.B., Shryock A.M., Paul O., Et al., Diet, serum cholesterol, and death from coronary disease: the Western electric study, N Engl J Med, 304, pp. 65-70, (1981)
[4]  
Keys A.B., Seven Countries: A Multivariate Analysis of Death and Coronary Disease, (1980)
[5]  
Dyer A.R., Stamler J., Paul O., Et al., Serum cholesterol and risk of death from cancer and other causes in three Chicago epidemiological studies, J Chron Dis, 34, pp. 249-60, (1981)
[6]  
Kark J.D., Smith A.H., Hames C.G., The relationship of serum cholesterol to the incidence of cancer in Evans County, Georgia, J Chron Dis, 33, pp. 311-22, (1980)
[7]  
Morris D.L., Borhani N.O., Fitzsimon E., Et al., Serum cholesterol and cancer in a hypertension detection and follow-up program, Cancer, 52, pp. 1754-9, (1983)
[8]  
Willia R.K., Sorlie P.D., Feinleib M., McNamara P.M., Kannel W.B., Dawber T.R., Cancer incidence by levels of cholesterol, JAMA, 245, pp. 247-52, (1981)
[9]  
Hiatt R.A., Friedman G.D., Bawol R.D., Ury H.K., Breast cancer and serum cholesterol, JNCL, 68, pp. 885-9, (1982)
[10]  
Tornberg S.A., Holm L.E., Carstensen J.M., Breast cancer risk in relation to serum cholesterol, serum β-lipoprotein, height, weight and blood pressure, Acta Oncologica, 126, pp. 922-8, (1988)